Enzo Biochem Return on Investment 2010-2022 | ENZ

Current and historical return on investment (ROI) values for Enzo Biochem (ENZ) over the last 10 years.
Enzo Biochem ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2022-04-30 $-0.01B $0.07B -15.77%
2022-01-31 $-0.01B $0.07B -8.51%
2021-10-31 $-0.00B $0.07B -2.87%
2021-07-31 $0.00B $0.07B 0.00%
2021-04-30 $0.00B $0.07B 0.00%
2021-01-31 $-0.01B $0.07B -18.53%
2020-10-31 $-0.02B $0.06B -32.84%
2020-07-31 $-0.03B $0.06B -41.67%
2020-04-30 $-0.03B $0.07B -40.63%
2020-01-31 $0.00B $0.08B 0.00%
2019-10-31 $-0.00B $0.08B -1.18%
2019-07-31 $0.00B $0.09B 1.56%
2019-04-30 $0.00B $0.10B 2.40%
2019-01-31 $-0.02B $0.07B -133.33%
2018-10-31 $-0.02B inf%
2018-07-31 $-0.01B inf%
2018-04-30 $-0.01B inf%
2018-01-31 $-0.01B inf%
2017-10-31 $-0.00B inf%
2017-07-31 $-0.00B inf%
2017-04-30 $0.04B inf%
2017-01-31 $0.03B inf%
2016-10-31 $0.04B inf%
2016-07-31 $0.05B inf%
2016-04-30 $0.02B inf%
2016-01-31 $0.02B inf%
2015-10-31 $0.01B inf%
2015-07-31 $-0.00B inf%
2015-04-30 $-0.01B inf%
2015-01-31 $-0.01B inf%
2014-10-31 $-0.01B inf%
2014-07-31 $-0.01B inf%
2014-04-30 $-0.01B inf%
2014-01-31 $-0.02B inf%
2013-10-31 $-0.02B inf%
2013-07-31 $-0.02B inf%
2013-04-30 $-0.05B inf%
2013-01-31 $-0.04B inf%
2012-10-31 $-0.04B inf%
2012-07-31 $-0.04B inf%
2012-04-30 $-0.02B inf%
2012-01-31 $-0.01B inf%
2011-10-31 $-0.02B inf%
2011-07-31 $-0.01B inf%
2011-04-30 $-0.02B inf%
2011-01-31 $-0.02B inf%
2010-10-31 $-0.02B inf%
2010-07-31 $-0.02B inf%
2010-04-30 $-0.02B inf%
2010-01-31 $-0.02B inf%
2009-10-31 $-0.02B inf%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.104B $0.118B
Enzo Biochem, Inc. develops, manufactures and markets health care products based on molecular biology and genetic engineering techniques, and also provides diagnostic services to the medical community. The business activities of the company are performed by one of the company's three wholly-owned subsidiaries--Enzo Diagnostics, Inc., Enzo Therapeutics, Inc., and Enzo Clinical Labs, Inc. The primary focus of the company's research is the development of products based on two technology platforms -- genetic modulation and immune modulation.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $163.597B 9.95
Bio-Rad Laboratories (BIO.B) United States $14.907B 32.33
QIAGEN (QGEN) Netherlands $10.865B 17.15
Biohaven Pharmaceutical Holding (BHVN) United States $10.248B 0.00
Ginkgo Bioworks Holdings (DNA) United States $4.228B 0.00
Arcus Biosciences (RCUS) United States $1.901B 48.18
Emergent Biosolutions (EBS) United States $1.599B 6.85
Myovant Sciences (MYOV) United Kingdom $1.236B 0.00
Zymeworks (ZYME) Canada $0.320B 0.00
Gelesis Holdings (GLS) United States $0.114B 0.00
Ambrx Biopharma (AMAM) United States $0.103B 0.00
SQZ Biotechnologies (SQZ) United States $0.087B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.000B 0.00